Dosidal · Poland
Morphini sulfas WZF
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
| Market | Poland |
|---|---|
| Record | pl:presentation:12754 (version 2) |
| Level | presentation |
| Pack code | gtin: 05909990405015 |
| Identifiers | rpl-pack-id: 12754 gtin: 05909990405015 |
| Source authority | URPL |
| Read date | 2026-11-15T02:02:49Z |
| controlled status | availability_category: Rpw definitions: https://eli.gov.pl/eli/DU/2016/1769/ogl/pol/pdf narcotic_or_psychotropic: True state: current · read 2026-11-15T02:02:49Z · source: URPL / Rejestr Produktów Leczniczych (Centrum e-Zdrowia export) page |
| identity | atc: N02AA01 authorisation_number: 04050 deleted: False form: Roztwór do wstrzykiwań holder: Zakłady Farmaceutyczne POLPHARMA S.A. medicine: Morphini sulfas WZF pack_units: jednostkaPojemnosci: ml liczbaOpakowan: 10 pojemnosc: 1 rodzajOpakowania: amp. procedure: NAR routes: domięśniowa; dożylna; podskórna strength: 20 mg/ml substances: amount: 20 substance: Morphini hemisulfas 2,5- hydricus unit: mg state: current · read 2026-11-15T02:02:49Z · source: URPL / Rejestr Produktów Leczniczych (Centrum e-Zdrowia export) page |
| pack product code | gs1_check_digit_valid: True gtin: 05909990405015 prefix_origin: GS1 Poland prefix 590 state: current · read 2026-11-15T02:02:49Z · source: URPL / Rejestr Produktów Leczniczych (Centrum e-Zdrowia export) page |
| prescription class | availability_category: Rpw definitions: https://eli.gov.pl/eli/DU/2016/1769/ogl/pol/pdf prescription: True state: current · read 2026-11-15T02:02:49Z · source: URPL / Rejestr Produktów Leczniczych (Centrum e-Zdrowia export) page |
| Signature | ES256 over JCS, key dosidal-record-1.9dbf5d53CDaZp35xlDeLKOcElNq5arZSC37eGnSGNv2zqRhG5sE8KTiXV9yt68mfUIT24MQNDG6fYEkxnRZ98g85njXsIQVerify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json |
JSON: https://dosidal-api.ai/v1/records/pl:presentation:12754 · Same medicine in other markets · Dosidal